261 results
8-K
EX-3.1
LCTX
Lineage Cell Therapeutics Inc
13 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
, or the Secretary, specifying the general nature of the business proposed to be transacted, sent by certified mail or delivered to such officer in person … and: (i) in the case of a special meeting, the general nature of the business to be transacted, and no other business may be transacted; or (ii
8-K
EX-3.1
LCTX
Lineage Cell Therapeutics Inc
13 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
the general nature of the business proposed to be transacted, sent by certified mail or delivered to such officer in person, by any person or persons … , and hour of the meeting and: (i) in the case of a special meeting, the general nature of the business to be transacted, and no other business may
424B5
LCTX
Lineage Cell Therapeutics Inc
14 May 24
Prospectus supplement for primary offering
4:36pm
with whom we have a material relationship. We will describe in the prospectus supplement, naming the underwriter, the nature of any such relationship.
If we
424B5
58xcm yhk22ozf8
22 Mar 24
Prospectus supplement for primary offering
4:32pm
8-K
o2kr4 5c8s
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-1.1
tz1fc7df1h p85vx
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
424B5
rhk fjjxlir4j
6 Feb 24
Prospectus supplement for primary offering
9:25am
8-K
EX-99.1
fufgti
11 May 23
LINEAGE CELL THERAPEUTICS REPORTs FIRST QUARTER 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
4:10pm